University of Minnesota. Driven to Discover.
Pending FDA approval, Johnson & Johnson is prepared to deliver 100 million doses by mid-summer.
The authors say the data support the CDC's prioritization of this group for vaccination.
Elsewhere, the UK says new cases involving SARS-CoV-2 variants are dropping sharply.
Data indicate amoxicillin-clavulanate is safe and effective and may cut the risk of fluoroquinolone-related harms.
Experts in health-system pharmacy say the potential for major disruptions will increase.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
Become an underwriter»
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2020 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.